Department of Anesthesiology and Perioperative Care and University of California San Francisco, San Francisco, California, USA.
Department of Laboratory Medicine, University of California San Francisco, San Francisco, California, USA.
Cannabis Cannabinoid Res. 2024 Oct;9(5):e1443-e1451. doi: 10.1089/can.2023.0121. Epub 2023 Oct 18.
Basic pharmacokinetic (PK) and pharmacodynamic models of the phytocannabinoids Δ-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are critical for developing translational models of exposure and toxicity. The neonatal period is a particularly important time to study the effects of cannabinoids, yet there are few studies of cannabinoid PKs by different routes such as direct injection or breast milk ingestion. To study this question, we have developed a translationally relevant rodent model of perinatal cannabinoid administration by measuring plasma levels of THC and CBD after different routes and preparations of these drugs. Adult animals and pups were injected with THC or CBD either intraperitoneally or subcutaneously, and plasma was analyzed by liquid chromatography-tandem mass spectrometry to measure cannabinoid levels collected at specified intervals. We also tested the effect of preparation of the drug using an oil-based vehicle (sesame oil) and an aqueous vehicle (Tween). Finally, we measured the plasma levels of cannabinoids in neonatal pups that were transmitted through breast milk after intraperitoneal injection to nursing dams. We observed differences in the PK profiles of cannabinoids in adults and neonatal pups that were dependent on the route of administration and type of vehicle. Cannabinoids prepared in aqueous vehicle, injected intraperitoneally, resulted in a high peak in plasma concentration, which rapidly decreased. In contrast, subcutaneous injections using sesame oil as a vehicle resulted in a slow rise and low plateau in plasma concentration. Intraperitoneal injections with sesame oil as a vehicle resulted in a slower rise compared with aqueous vehicle, but an earlier and higher peak compared with subcutaneous injection. Finally, the levels of THC and CBD that were similar to direct subcutaneous injections were measured in the plasma of pups nursing from intraperitoneally injected dams. The route of administration and the preparation of the drug have important and significant effects on the PK profiles of THC and CBD in rats. These results can be used to create different clinically relevant exposure paradigms in pups and adults, such as short high-dose exposure or a low-chronic exposure, each of which might have significant and varying effects on development.
植物大麻素 Δ-9-四氢大麻酚(THC)和大麻二酚(CBD)的基本药代动力学(PK)和药效动力学模型对于开发暴露和毒性的转化模型至关重要。新生儿期是研究大麻素影响的特别重要的时期,但很少有关于不同途径(如直接注射或母乳摄入)的大麻素 PK 研究。为了研究这个问题,我们通过测量不同途径和药物制剂后血浆中的 THC 和 CBD 水平,开发了一种与围产期大麻素给药相关的转化啮齿动物模型。成年动物和幼崽通过腹膜内或皮下注射 THC 或 CBD,通过液相色谱-串联质谱法分析血浆,以测量特定时间间隔收集的大麻素水平。我们还测试了使用油基载体(芝麻油)和水基载体(吐温)制备药物的效果。最后,我们测量了通过腹膜内注射到哺乳母鼠后通过母乳传递给新生幼崽的大麻素的血浆水平。
我们观察到,在成年动物和新生幼崽中,大麻素的 PK 特征取决于给药途径和载体类型,存在差异。在水中制备的药物,腹膜内注射,导致血浆浓度迅速下降的高峰。相比之下,芝麻油作为载体的皮下注射导致血浆浓度缓慢上升和低平台。与水基载体相比,芝麻油作为载体的腹膜内注射导致上升较慢,但与皮下注射相比,上升更早且更高。最后,在从腹膜内注射的母鼠哺乳的幼崽的血浆中测量到与直接皮下注射相似的 THC 和 CBD 水平。
给药途径和药物制剂对大鼠 THC 和 CBD 的 PK 特征有重要和显著的影响。这些结果可用于在幼崽和成年动物中创建不同的临床相关暴露范例,例如短时间高剂量暴露或低慢性暴露,每种暴露都可能对发育产生重大且不同的影响。